Drug firms call on FDA to add to guidance on trial enrichment

03/25/2013 | OutSourcing-Pharma.com

Large drug firms including Merck & Co., Eli Lilly and Co. and Pfizer urged the FDA to bolster its draft guidance on enrichment measures for clinical trials with additional examples involving various therapeutic areas. Pharmaceutical companies also called for increased guidance involving diagnostics.

View Full Article in:

OutSourcing-Pharma.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY